Reply to Wang and Zhou
- PMID: 36638560
- PMCID: PMC10037480
- DOI: 10.1164/rccm.202212-2214LE
Reply to Wang and Zhou
Figures

Comment on
-
Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising Natural Killer T Cell-based Therapy.Am J Respir Crit Care Med. 2023 Mar 15;207(6):795-796. doi: 10.1164/rccm.202211-2134LE. Am J Respir Crit Care Med. 2023. PMID: 36638561 Free PMC article. No abstract available.
References
-
- Jandl K, Marsh LM, Mutgan AC, Crnkovic S, Valzano F, Zabini D, et al. Impairment of the NKT-STAT1-CXCL9 axis contributes to vessel fibrosis in pulmonary hypertension caused by lung fibrosis. Am J Respir Crit Care Med . 2022;206:981–998. - PubMed
-
- Hoffmann J, Wilhelm J, Marsh LM, Ghanim B, Klepetko W, Kovacs G, et al. Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension. Am J Respir Crit Care Med . 2014;190:98–111. - PubMed
-
- Romero-Olmedo AJ, Schulz AR, Huber M, Brehm CU, Chang HD, Chiarolla CM, et al. Deep phenotypical characterization of human CD3+ CD56+ T cells by mass cytometry. Eur J Immunol . 2021;51:672–681. - PubMed
-
- Damayanti T, Kikuchi T, Zaini J, Daito H, Kanehira M, Kohu K, et al. Serial OX40 engagement on CD4+ T cells and natural killer T cells causes allergic airway inflammation. Am J Respir Crit Care Med . 2010;181:688–698. - PubMed
Publication types
LinkOut - more resources
Full Text Sources